Certara Inc
CERT
Market Cap$2.17B
Close$
$8.42
37% downside
Current Fair Value
37% downsideOvervalued by 37% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.17 Billion |
|---|---|
| Enterprise Value | $2.23 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-0.39 |
| Beta | 1.47 |
| Outstanding Shares | 160,841,451 |
| Avg 30 Day Volume | 629,520 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -35.29 |
|---|---|
| PEG | 7.93 |
| Price to Sales | 6.68 |
| Price to Book Ratio | 2.23 |
| Enterprise Value to Revenue | 6.19 |
| Enterprise Value to EBIT | -887.69 |
| Enterprise Value to Net Income | -37 |
| Total Debt to Enterprise | 0.13 |
| Debt to Equity | 0.28 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Certara Inc
300 employeesCertara optimizes R&D productivity, commercial value and patient outcomes through its unique portfolio of model-informed drug development, regulatory science, and market access solutions. In fact, 90+% of all novel drugs approved by the ...